This site is intended for US Residents only.

Selected Important Safety Information

  • Do not use ELOCTATE if you have had an
    allergic reaction to it in the past.
Please see below for additional Important Safety
Information and full Prescribing Information.
My son’s bleed
protection* is my
top priority

Being a caregiver of someone with
Hemophilia can bring challenges, as
well as unexpected rewards. But
often the hardest part of your journey
is seeking answers. That’s why we’re
dedicated to helping caregivers like
you learn about a treatment to
consider discussing with your
son’s doctor.
*ELOCTATE has been proven to help patients prevent bleeding episodes using a prophylaxis regimen.

The recommended starting regimen is 50 IU/kg of ELOCTATE administered every 4 days. Adjust the regimen based on patient response, with dosing in the range of 25-65 IU/kg at 3-5 day intervals.

For children under 6 years old, the recommended starting regimen is 50 IU/kg of ELOCTATE administered twice weekly. Adjust the regimen based on patient response with dosing in the range of 25-65 IU/kg at 3-5 day intervals. More frequent or higher doses up to 80 IU/kg may be required.
Note: This is a personal account of a MyELOCTATE Peer™. Please talk to your child’s healthcare provider
about whether ELOCTATE may be right for him. Individual results may vary.
Meet Charity, A MyELOCTATE Peer™ Her son with severe Hemophilia A participates in track and field. So they’ve worked with his
doctor to put him on an every-four-day ELOCTATE prophylaxis infusion schedule to keep him
protected from bleeds.

Watch Charity’s story.

Selected Important Safety Information

  • Tell your healthcare provider if you have or have had any medical problems, take any medicines, including prescription and
    non-prescription medicines, supplements, or herbal medicines, have any allergies, are breastfeeding, are pregnant or planning
    to become pregnant, or have been told you have inhibitors (antibodies) to Factor VIII.
Please see below for additional Important Safety Information and full Prescribing Information.
Could ELOCTATE be right for your child?
Take a moment to learn about the potential
benefits and risks of ELOCTATE.
I’m growing
more independent
and managing
my treatment

You want to get out there, explore, and
enjoy the adventure of life. We get it.
That’s why we’re doing our part to help
you learn about a treatment to consider
discussing with your doctor so you can
focus on making time for what matters
to you.
The recommended starting regimen is 50 IU/kg of ELOCTATE administered every 4 days. Adjust the regimen based on patient response, with dosing in the range of 25-65 IU/kg at 3-5 day intervals.

For children under 6 years old, the recommended starting regimen is 50 IU/kg of ELOCTATE administered twice weekly. Adjust the regimen based on patient response with dosing in the range of 25-65 IU/kg at 3-5 day intervals. More frequent or higher doses up to 80 IU/kg may be required.
Note: This is a personal account of a MyELOCTATE Peer™. Please talk to your healthcare provider
about whether ELOCTATE may be right for you. Individual results may vary.
Meet Andres, A MyELOCTATE Peer™ Until he decided to take treatment more seriously, he missed infusions and opportunities.
Over time, Andres became familiar and confident with a prophy regimen. Then he asked
his doctor about ELOCTATE.

Watch Andres’s story.

Selected Important Safety Information

  • Allergic Reactions may occur with ELOCTATE. Call your healthcare provider or get emergency treatment right away if you
    have any of the following symptoms: difficulty breathing, chest tightness, swelling of the face, rash, or hives.
Please see below for additional Important Safety Information and full Prescribing Information.
Could ELOCTATE be right for you?
Take a moment to learn about the potential
benefits and risks of ELOCTATE.
After managing my
Hemophilia for years,
I’m exploring
treatment options

You have a lot on your mind already. And
perhaps transitioning your treatment
isn’t currently one of them. That’s why
we’re doing our part to help you learn
about a treatment to consider
discussing with your doctor so you can
focus on making time for what matters
to you.
The recommended starting regimen is 50 IU/kg of ELOCTATE administered every 4 days. Adjust the regimen based on patient response, with dosing in the range of 25-65 IU/kg at 3-5 day intervals.

For children under 6 years old, the recommended starting regimen is 50 IU/kg of ELOCTATE administered twice weekly. Adjust the regimen based on patient response with dosing in the range of 25-65 IU/kg at 3-5 day intervals. More frequent or higher doses up to 80 IU/kg may be required.
Note: This is a personal account of a MyELOCTATE Peer™. Please talk to your healthcare provider
about whether ELOCTATE may be right for you. Individual results may vary.
Meet Craig, A MyELOCTATE Peer™ After decades on factor VIII concentrate, he transitioned to ELOCTATE.
He approached this treatment transition the same way he’s approached life—with
a sense of possibility.

Watch Craig’s story.

Selected Important Safety Information

  • The most frequently occurring side effects of ELOCTATE are headache, rash, joint pain, muscle pain and general discomfort. These are not all the possible side effects of ELOCTATE. Talk to your healthcare provider right away about any side effect that bothers you or that does not go away, and if bleeding is not controlled after using ELOCTATE.
Please see below for additional Important Safety Information and full Prescribing Information.
Could ELOCTATE be right for you?
Take a moment to learn about the potential
benefits and risks of ELOCTATE.
*ELOCTATE has been proven to help patients prevent
  bleeding episodes using a prophylaxis regimen

Indications and Important Safety Information

Indications

ELOCTATE [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is a recombinant DNA derived, antihemophilic factor indicated in adults and children with Hemophilia A (congenital Factor VIII deficiency) for: on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to reduce the frequency of bleeding episodes. ELOCTATE is not indicated for the treatment of von Willebrand disease.

Important Safety Information

Do not use ELOCTATE if you have had an allergic reaction to it in the past.

Tell your healthcare provider if you have or have had any medical problems, take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines, have any allergies, are breastfeeding, are pregnant or planning to become pregnant, or have been told you have inhibitors (antibodies) to Factor VIII.

Allergic reactions may occur with ELOCTATE. Call your healthcare provider or get emergency treatment right away if you have any of the following symptoms: difficulty breathing, chest tightness, swelling of the face, rash, or hives.

Your body can also make antibodies called, "inhibitors," against ELOCTATE, which may stop ELOCTATE from working properly.

The most frequently occurring side effects of ELOCTATE are headache, rash, joint pain, muscle pain and general discomfort. These are not all the possible side effects of ELOCTATE. Talk to your healthcare provider right away about any side effect that bothers you or that does not go away, and if bleeding is not controlled after using ELOCTATE.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please see full Prescribing Information.